Unjha Formulations Balance Sheet Annual

BSE: 531762 | NSE: - | ISIN: INE576D01015 | Sector: Biotechnology & Drugs

26.13 -1.36 (-4.95%)Updated : 19 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	5.51	4.56	4.93	3.41
Cash Equivalents	1.64	0.64	0.87	0.01
Common Stock Total	4.48	4.48	4.48	4.48
Other Equity Total	-0.64	-1.34	-1.75	-2.03
Other Current Assets Total	0.59	0.06	0.00	0.12
Total Assets	5.51	4.56	4.93	3.41
Total Equity	3.84	3.14	2.73	2.45
Total Common Shares Outstanding	0.45	0.45	0.45	0.45
Tangible Book Valueper Share Common Eq	7.46	5.89	4.98	4.36
Total Liabilities	1.67	1.42	2.20	0.96
Total Debt	0.00	0.00	0.00	0.00
Cashand Short Term Investments	1.64	0.64	0.87	0.01
Total Receivables Net	1.35	1.62	1.68	1.05
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Deferred Income Tax	0.00	0.00	0.01	0.00
Accounts Receivable- Trade Net	1.35	1.51	1.61	1.05
Property/ Plant/ Equipment Total- Net	0.80	0.70	0.62	0.60
Total Current Liabilities	1.67	1.41	2.20	0.96
Total Inventory	0.63	1.03	1.26	1.14
Accounts Payable	1.31	1.17	2.04	0.94
Other Currentliabilities Total	0.36	0.25	0.15	0.02
Total Long Term Debt	0.00	0.00	0.00	0.00
Intangibles Net	0.50	0.50	0.50	-
Other Long Term Assets Total	0.00	-	-	-
Total Current Assets	4.21	3.35	3.81	2.31
period Length	0.00	0.00	0.00	0.00
Other Liabilities Total	-	0.00	-	-
Goodwill Net	-	-	-	0.50